Connection

C Metcalf to Humans

This is a "connection" page, showing publications C Metcalf has written about Humans.
Connection Strength

0.121
  1. Building toward useful SARS-CoV-2 models in Africa. Proc Natl Acad Sci U S A. 2021 08 03; 118(31).
    View in: PubMed
    Score: 0.008
  2. The limits of SARS-CoV-2 predictability. Nat Ecol Evol. 2021 08; 5(8):1052-1054.
    View in: PubMed
    Score: 0.008
  3. Variation in SARS-CoV-2 outbreaks across sub-Saharan Africa. Nat Med. 2021 03; 27(3):447-453.
    View in: PubMed
    Score: 0.007
  4. Disentangling the dynamical underpinnings of differences in SARS-CoV-2 pathology using within-host ecological models. PLoS Pathog. 2020 12; 16(12):e1009105.
    View in: PubMed
    Score: 0.007
  5. Mathematical models to guide pandemic response. Science. 2020 07 24; 369(6502):368-369.
    View in: PubMed
    Score: 0.007
  6. Using Serology with Models to Clarify the Trajectory of the SARS-CoV-2 Emerging Outbreak. Trends Immunol. 2020 10; 41(10):849-851.
    View in: PubMed
    Score: 0.007
  7. Disease and healthcare burden of COVID-19 in the United States. Nat Med. 2020 08; 26(8):1212-1217.
    View in: PubMed
    Score: 0.007
  8. Which interventions work best in a pandemic? Science. 2020 Jun 05; 368(6495):1063-1065.
    View in: PubMed
    Score: 0.007
  9. Demographically framing trade-offs between sensitivity and specificity illuminates selection on immunity. Nat Ecol Evol. 2017 Nov; 1(11):1766-1772.
    View in: PubMed
    Score: 0.006
  10. Identifying climate drivers of infectious disease dynamics: recent advances and challenges ahead. Proc Biol Sci. 2017 Aug 16; 284(1860).
    View in: PubMed
    Score: 0.006
  11. Opportunities and challenges in modeling emerging infectious diseases. Science. 2017 Jul 14; 357(6347):149-152.
    View in: PubMed
    Score: 0.006
  12. Opportunities and challenges of a World Serum Bank - Authors' reply. Lancet. 2017 01 21; 389(10066):252.
    View in: PubMed
    Score: 0.006
  13. Vaccine nationalism and the dynamics and control of SARS-CoV-2. Science. 2021 09 24; 373(6562):eabj7364.
    View in: PubMed
    Score: 0.002
  14. Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world. Elife. 2021 07 13; 10.
    View in: PubMed
    Score: 0.002
  15. Maximizing and evaluating the impact of test-trace-isolate programs: A modeling study. PLoS Med. 2021 04; 18(4):e1003585.
    View in: PubMed
    Score: 0.002
  16. Household COVID-19 risk and in-person schooling. Science. 2021 06 04; 372(6546):1092-1097.
    View in: PubMed
    Score: 0.002
  17. Partial immunity and SARS-CoV-2 mutations-Response. Science. 2021 04 23; 372(6540):354-355.
    View in: PubMed
    Score: 0.002
  18. Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes. Science. 2021 04 23; 372(6540):363-370.
    View in: PubMed
    Score: 0.002
  19. Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys. Elife. 2021 03 05; 10.
    View in: PubMed
    Score: 0.002
  20. Assessing the influence of climate on wintertime SARS-CoV-2 outbreaks. Nat Commun. 2021 02 08; 12(1):846.
    View in: PubMed
    Score: 0.002
  21. Trajectory of individual immunity and vaccination required for SARS-CoV-2 community immunity: a conceptual investigation. J R Soc Interface. 2021 02; 18(175):20200683.
    View in: PubMed
    Score: 0.002
  22. Monitoring for outbreak-associated excess mortality in an African city: Detection limits in Antananarivo, Madagascar. Int J Infect Dis. 2021 Feb; 103:338-342.
    View in: PubMed
    Score: 0.002
  23. The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections. Proc Natl Acad Sci U S A. 2020 12 01; 117(48):30547-30553.
    View in: PubMed
    Score: 0.002
  24. The use of mobile phone data to inform analysis of COVID-19 pandemic epidemiology. Nat Commun. 2020 09 30; 11(1):4961.
    View in: PubMed
    Score: 0.002
  25. Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years. Science. 2020 11 13; 370(6518):811-818.
    View in: PubMed
    Score: 0.002
  26. Seroepidemiologic Study Designs for Determining SARS-COV-2 Transmission and Immunity. Emerg Infect Dis. 2020 Sep; 26(9):1978-1986.
    View in: PubMed
    Score: 0.002
  27. A Global lmmunological Observatory to meet a time of pandemics. Elife. 2020 06 08; 9.
    View in: PubMed
    Score: 0.002
  28. Susceptible supply limits the role of climate in the early SARS-CoV-2 pandemic. Science. 2020 07 17; 369(6501):315-319.
    View in: PubMed
    Score: 0.002
  29. Aggregated mobility data could help fight COVID-19. Science. 2020 04 10; 368(6487):145-146.
    View in: PubMed
    Score: 0.002
  30. Healthcare utilization, provisioning of post-exposure prophylaxis, and estimation of human rabies burden in Madagascar. Vaccine. 2019 10 03; 37 Suppl 1:A35-A44.
    View in: PubMed
    Score: 0.002
  31. Urbanization and humidity shape the intensity of influenza epidemics in U.S. cities. Science. 2018 10 05; 362(6410):75-79.
    View in: PubMed
    Score: 0.002
  32. Epidemic dynamics, interactions and predictability of enteroviruses associated with hand, foot and mouth disease in Japan. J R Soc Interface. 2018 09 12; 15(146).
    View in: PubMed
    Score: 0.002
  33. The geography of measles vaccination in the African Great Lakes region. Nat Commun. 2017 05 25; 8:15585.
    View in: PubMed
    Score: 0.001
  34. Spatial and temporal dynamics of superspreading events in the 2014-2015 West Africa Ebola epidemic. Proc Natl Acad Sci U S A. 2017 02 28; 114(9):2337-2342.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.